HLS Therapeutics Inc.

HLS.TOReports Thu, Nov 12 · Q3 2026
$4.47−$0.04 −0.89%At close · November 2
Price1Y range $3.60 – $5.50

Estimation history is only available for connected users.

vs. 4-yr trend
RATIO TREND TTM
Free Cash Flow Ratiosgreen ≥ 5%
'23 → TTM
32.28%
Net Income Margin Ratiosgreen ≥ 15%
'23 → TTM
-15.24%
Return on Equity Ratiosgreen ≥ 15%
'23 → TTM
-14.07%
Return on Asset Ratiosgreen ≥ 7%
'23 → TTM
-2.03%
Total Revenue YoY Growth -0.32%
Cash from Ops YoY Growth 41.99%
Your HLS.TO research, in one place

Sign in to keep private notes and post comments other investors can read.

Sign In
An unhandled error has occurred. Reload 🗙